(Q41368236)

English

Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70).

scientific article published on 30 March 2015

In more languages
default values for all languages
No label defined

No description defined

Statements

Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70). (English)
Christian Jackisch
Holger Eidtmann
Jens Uwe Blohmer
Nicole Burchardi
Gunter von Minckwitz

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit